<DOC>
	<DOC>NCT01104480</DOC>
	<brief_summary>This is a study for one patient with severe relapsing polychondritis which has been unresponsive to other more conventional medications including prednisone, methotrexate, anakinra and TNF inhibitors. Tolerability, and efficacy of the drug, Tocilizumab will be monitored by clinical assessment and bloodwork.</brief_summary>
	<brief_title>Tocilizumab for Relapsing Polychondritis</brief_title>
	<detailed_description />
	<mesh_term>Polychondritis, Relapsing</mesh_term>
	<criteria>A single patient with unremitting inflammatory relapsing polychondritis As this is a study in a single patient, there are no exclusions</criteria>
	<gender>Male</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Relapsing Polychondritis</keyword>
	<keyword>Unremitting</keyword>
	<keyword>Inflammation</keyword>
	<keyword>IL6</keyword>
</DOC>